Long-Term Effects of Teriparatide Followed by Antiresorptive Therapy on Clinical Outcomes in Patients with Severe Spinal Osteoporosis

Effect of Parathyroid Hormone (1-34) on Fractures and Bone Mineral Density in Postmenopausal Women with Osteoporosis

Robert M. Neer, Claude D. Arnaud, José Zanchetta et al. · New England Journal of Medicine · 2001 · 4.5K citations

Teriparatide or Alendronate in Glucocorticoid-Induced Osteoporosis

Kenneth G. Saag, Elizabeth Shane, Steven Boonen et al. · New England Journal of Medicine · 2007 · 891 citations · Full text

Effects of teriparatide and risedronate on new fractures in post-menopausal women with severe osteoporosis (VERO): a multicentre, double-blind, double-dummy, randomised controlled trial

David L. Kendler, Fernando Marín, Cristiano A. F. Zerbini et al. · The Lancet · 2017 · 554 citations · Full text

Bone Disease, Bone Health, New Fractures +8

A Randomized Double-Blind Trial to Compare the Efficacy of Teriparatide [Recombinant Human Parathyroid Hormone (1–34)] with Alendronate in Postmenopausal Women with Osteoporosis

Jean‐Jacques Body, Gregory Gaich, Wim H. Scheele et al. · The Journal of Clinical Endocrinology & Metabolism · 2002 · 359 citations

The effect of teriparatide compared with risedronate on reduction of back pain in postmenopausal women with osteoporotic vertebral fractures

Peyman Hadji, José Zanchetta, Luis Augusto Tavares Russo et al. · Osteoporosis International · 2011 · 133 citations

Pain Medicine, Geriatric Fracture Care, Surgery +8